CARPENTIER-EDWARDS PERIMOUNT PLUS PERICARDIAL BIOPROSTHESIS
Report
- Report Number
- 2015691-2010-14116
- Event Type
- Death
- Date Received
- September 24, 2010
- Date of Event
- June 15, 2010
- Report Date
- September 2, 2010
- Manufacturer
- EDWARDS LIFESCIENCES
- Product Code
- DYE
- PMA / PMN Number
- P860057/S016
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- PHYSICIAN
Narratives
THROUGH FOLLOW-UP WITH THE HEALTH-CARE PROVIDER, A COPY OF THE OPERATIVE REPORT WAS RECEIVED. IT WAS LEARNED THAT THE DEVICE WAS EXPLANTED ON (B)(6) 2010 DUE TO MITRAL STENOSIS. IT WAS ALSO LEARNED THAT THE PATIENT EXPIRED ON (B)(6) 2010 FROM RIGHT HEART FAILURE AND PULMONARY HYPERTENSION. PER THE OPERATIVE REPORT OF (B)(6) 2010, THE PATIENT HAD "...SEVERE MITRAL STENOSIS ACROSS A STENOTIC PORCINE PROSTHESIS AND THERE WAS MILD TO MODERATE AORTIC REGURGITATION. TRICUSPID REGURGITATION WAS SEVERED." THEREFORE, A MVR, AVR, AND A TRICUSPID ANNULOPLASTY PERFORMED. "SEPARATION FROM BYPASS WAS ACHIEVED BUT ALTHOUGH THE LEFT SIDE OF THE HEART WAS VIGOROUS AND CONTRACTING WELL, THE RIGHT SIDE REMAINED ESSENTIALLY NON-MOVING WITH SIGNIFICANT PULMONARY HYPERTENSION. THERE WAS NO TRICUSPID REGURGITATION. AFTER A MIXTURE OF INOTROPES, AN INFUSION OF ADRENALIN AND NORADRENALINE TOGETHER WITH DOBUTAMINE AND NITRIC SHE WAS TRANSFERRED ONTO THE BED. SHORTLY AFTER THIS HER PRESSURES DETERIORATED REQUIRING INCREASING AMOUNTS OF INOTROPE AND IT WAS CLEAR THAT THE RIGHT SIDE OF HER HEART WAS TOTALLY NON-FUNCTIONING DESPITE ALL RESUSCITIVE MEASURES. SHE CONTINUED TO DETERIORATE AND DECEASED IN THE OPERATIVE THEATRE AT APPROXIMATELY 1710 HOURS. THE CORONER WAS INFORMED."
ON 12/01/2010, THE SALES REP TALKED TO THE CLINICAL NURSE AND WAS TOLD THE DEVICE HAD BEEN DISCARDED. THEREFORE, THE DEVICE WILL NOT BE RETURNED AND NO EVALUATION OF THE DEVICE WILL BE DONE. STENOSIS IS THE REASON FOR EXPLANT OF THE MITRAL VALVE. STENOSIS CAN BE DUE TO MANY FACTORS DEPENDING ON THE IMPLANT DURATION INCLUDING, BUT NOT LIMITED TO: CALCIFICATION, THROMBOSIS AND PANNUS. WE, UNFORTUNATELY, ARE UNABLE TO EVALUATE THE DEVICE TO DETERMINE THE ROOT CAUSE OF THE STENOSIS.
DEVICE NOT RETURNED. THE INFORMATION WAS LEARNED THROUGH IMPLANT PATIENT REGISTRY. THE PATIENT ALSO HAD ANOTHER DEVICE IMPLANTED, (B)(4). TWO REQUESTS WERE MADE TO THE HEALTH-CARE PROVIDER (VIA E-MAIL) FOR THE DEVICE, OPERATIVE REPORT, AND ADDITIONAL INFORMATION; HOWEVER, NO ADDITIONAL INFORMATION WAS RECEIVED. THE DEVICE HISTORY RECORD (DHR) REVIEW WAS COMPLETED, AND THIS DEVICE PASSED ALL MANUFACTURING AND STERILIZATION INSPECTIONS WITH NO NONCONFORMANCE.
IT WAS REPORTED THAT THE PATIENT HAS EXPIRED AFTER AN IMPLANT DURATION OF 43.5 MONTHS, DUE TO UNKNOWN REASONS. IT IS UNKNOWN IF THE DEATH WAS DEVICE RELATED. NO FURTHER DETAILS WERE PROVIDED.
THE PATIENT RECEIVED TWO OVERLAPPING CYPHER STENTS IN THE RIGHT CORONARY ARTERY. THREE AND A HALF YEARS AFTER THE INDEX PROCEDURE THE PATIENT CAME IN FOR ADDITIONAL TREATMENT AND THE PHYSICIAN FOUND STENT FRACTURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CARPENTIER-EDWARDS PERIMOUNT PLUS PERICARDIAL BIOPROSTHESIS | REPLACEMENT HEART VALVE | DYE | EDWARDS LIFESCIENCES | 6900P | 04H047 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 44 YR | Death |